Acromegaly Completed Phase 2 / 3 Trials for Lanreotide (DB06791)

Back to Acromegaly

Also known as: Acromegalic / Acromegaly (disorder)

IndicationStatusPhase
DBCOND0000951 (Acromegaly)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00234572
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With AcromegalyTreatment